Tinea unguium
MONDO:0001628A fungal infection of the nail, usually caused by dermatophytes; yeasts; or nondermatophyte molds.
Also known as: dermatophytic onychia, dermatophytosis of nail, nail dermatophytosis, onychomycosis, tinea unguium
14 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New serum combo takes on stubborn toenail fungus
Disease control CompletedThis completed study tested two topical serums for treating toenail fungus (onychomycosis). 44 adults with mild to moderate infection applied one or both serums daily for 112 days. Researchers measured the change in healthy nail area using photos. The goal was to see if using bot…
Phase: NA • Sponsor: Swiss Footcare Laboratories - Poderm Professional • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New light therapy takes on stubborn toenail fungus
Disease control CompletedThis study tested two treatments for toenail fungus in 27 Asian adults: a light-activated dye (methylene blue photodynamic therapy) and a medicated nail polish (amorolfine). The goal was to see which worked better and was safer. Participants received either the light treatment or…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Light shines on fungus: new device tackles toenail infection
Disease control CompletedThis study tested a light therapy device called ToeFX for mild to moderate toenail fungus. 126 people with fungal infection in one big toenail used the device. Researchers measured new clear nail growth after 12 months to see if the treatment worked and was safe.
Phase: NA • Sponsor: ToeFX Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New gel shows promise for ugly toenail fungus
Disease control CompletedThis study tested a special gel, CGB-400, on 15 adults with toenail fungus. The goal was to see if the gel could clear the fungus and make the nails look better. Participants applied the gel for 12 weeks, with follow-up visits to check progress.
Sponsor: CAGE Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
One shot wonder? new antibiotic trial for Kids' skin infections
Disease control CompletedThis study tested a single dose of the antibiotic oritavancin in 118 children aged 3 months to 12 years with acute bacterial skin infections. The goal was to see if it is safe and tolerable. Researchers also looked at how the drug works in the body and whether it cures the infect…
Phase: PHASE2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC